The authors intriguingly show that uPAR-specific CAR T-cell therapy improves the treatment outcome of lung adenocarcinomas and efficiently reduces liver fibrosis in mouse models, thus offering a promising novel therapeutic strategy for senescence-associated diseases (Fig.1). This evidence concerns the gene PLAUR and Hepatic fibrosis.